Halozyme Therapeutics Overview
Halozyme Therapeutics Target Price
Analysts' 12-month price predictions for HALO.
Get informed when a big investor buys or sells
+ FollowShare Price
$79.45
Average Target Price
$93.50
17.7% upside
17.7% upside4 analysts in the last 4 months
High: $96 | Low: $90
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-03 | UBS | $90 | 13.3% upside |  |
| 2026-05-12 | Morgan Stanley | $93 | 17.1% upside | |
| 2026-04-29 | H.C. WainwrightMitchell Kapoor | $95 | 19.6% upside | |
| 2026-04-21 | Morgan Stanley | $96 | 20.8% upside | |
| 2026-02-19 | Morgan Stanley | $94 | 18.3% upside | |
| 2026-02-19 | Wells Fargo | $75 |  5.6% downside | |
| 2026-01-08 | Morgan Stanley | $75 | 5.6% downside | |
| 2025-12-04 | UBS | $56 | 29.5% downside | |
| 2025-12-04 | Goldman SachsCorinne Jenkins | $56 | 29.5% downside | |
| 2025-11-04 | JMP Securities | $92 | 15.8% upside | |
| 2025-10-20 | Morgan Stanley | $79 | 0.6% downside | |
| 2025-10-14 | Leerink Partners | $70 | 11.9% downside | |
| 2025-10-02 | H.C. Wainwright | $90 | 13.3% upside | |
| 2025-05-14 | Morgan StanleySean Laaman | $62 | 22% downside | |
| 2024-11-15 | Piper SandlerJoseph Catanzaro | $52 | 34.6% downside | |
| 2024-06-07 | H.C. WainwrightMitchell Kapoor | $65 | 18.2% downside | |
| 2024-06-07 | Piper SandlerJoseph Catanzaro | $51 | 35.8% downside | |
| 2024-06-07 | Wells FargoMohit Bansal | $58 | 27% downside | |
| 2024-06-06 | Goldman SachsCorinne Jenkins | $44 | 44.6% downside | |
| 2023-01-11 | Leerink Partners | $61 | 23.2% downside | |
| 2022-12-21 | Morgan Stanley | $65 | 18.2% downside | |
| 2022-11-28 | Wells Fargo | $65 | 18.2% downside | |
| 2022-11-22 | J.P. Morgan | $54 | 32% downside | |